These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37098849)

  • 1. Randomized controlled trial of slow peanut oral immunotherapy in young children: SmaChO study protocol.
    Uhl C; Sverremark-Ekström E; Borres M; Ebisawa M; Melén E; Mäkelä MJ; Konradsen JR; Vickery BP; Asarnoj A; Nilsson C
    Clin Exp Allergy; 2023 May; 53(5):594-597. PubMed ID: 37098849
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral immunotherapy for peanut allergy shows promise but questions remain.
    Kmietowicz Z
    BMJ; 2014 Jan; 348():g1265. PubMed ID: 24480396
    [No Abstract]   [Full Text] [Related]  

  • 3. Low dose immunotherapy in very young children to treat peanut allergy.
    Vickery BP
    Expert Rev Clin Immunol; 2016 Dec; 12(12):1251-1253. PubMed ID: 27599211
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
    Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
    Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peanut allergy. Desensitization by oral immunotherapy].
    Ziegler R
    Med Monatsschr Pharm; 2014 Jul; 37(7):266-7. PubMed ID: 25065168
    [No Abstract]   [Full Text] [Related]  

  • 7. Current opinion and review on peanut oral immunotherapy.
    Deol S; Bird JA
    Hum Vaccin Immunother; 2014; 10(10):3017-21. PubMed ID: 25483680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
    Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
    BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial.
    Michaud E; Evrard B; Pereira B; Rochette E; Bernard L; Rouzaire PO; Gourdon-Dubois N; Merlin E; Fauquert JL
    Trials; 2015 Apr; 16():197. PubMed ID: 25925398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison.
    Chin SJ; Vickery BP; Kulis MD; Kim EH; Varshney P; Steele P; Kamilaris J; Hiegel AM; Carlisle SK; Smith PB; Scurlock AM; Jones SM; Burks AW
    J Allergy Clin Immunol; 2013 Aug; 132(2):476-8.e2. PubMed ID: 23534975
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse reactions during peanut oral immunotherapy home dosing.
    Varshney P; Steele PH; Vickery BP; Bird JA; Thyagarajan A; Scurlock AM; Perry TT; Jones SM; Burks AW
    J Allergy Clin Immunol; 2009 Dec; 124(6):1351-2. PubMed ID: 19913285
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.
    Bird JA; Spergel JM; Jones SM; Rachid R; Assa'ad AH; Wang J; Leonard SA; Laubach SS; Kim EH; Vickery BP; Davis BP; Heimall J; Cianferoni A; MacGinnitie AJ; Crestani E; Burks AW;
    J Allergy Clin Immunol Pract; 2018; 6(2):476-485.e3. PubMed ID: 29092786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
    Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
    J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peanut allergy and oral immunotherapy.
    Lee TH; Chan JKC; Lau PC; Luk WP; Fung LH
    Hong Kong Med J; 2019 Jun; 25(3):228-234. PubMed ID: 31178442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peanut Allergen Powder (Palforzia) for Peanut Allergy.
    Erlich D
    Am Fam Physician; 2022 Jan; 105(1):20-21. PubMed ID: 35029941
    [No Abstract]   [Full Text] [Related]  

  • 16. Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
    Fernandez-Rivas M; Vereda A; Vickery BP; Sharma V; Nilsson C; Muraro A; Hourihane JO; DunnGalvin A; du Toit G; Blumchen K; Beyer K; Smith A; Ryan R; Adelman DC; Jones SM
    Allergy; 2022 Mar; 77(3):991-1003. PubMed ID: 34320250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AR101 Oral Immunotherapy for Peanut Allergy.
    ; Vickery BP; Vereda A; Casale TB; Beyer K; du Toit G; Hourihane JO; Jones SM; Shreffler WG; Marcantonio A; Zawadzki R; Sher L; Carr WW; Fineman S; Greos L; Rachid R; Ibáñez MD; Tilles S; Assa’ad AH; Nilsson C; Rupp N; Welch MJ; Sussman G; Chinthrajah S; Blumchen K; Sher E; Spergel JM; Leickly FE; Zielen S; Wang J; Sanders GM; Wood RA; Cheema A; Bindslev-Jensen C; Leonard S; Kachru R; Johnston DT; Hampel FC; Kim EH; Anagnostou A; Pongracic JA; Ben-Shoshan M; Sharma HP; Stillerman A; Windom HH; Yang WH; Muraro A; Zubeldia JM; Sharma V; Dorsey MJ; Chong HJ; Ohayon J; Bird JA; Carr TF; Siri D; Fernández-Rivas M; Jeong DK; Fleischer DM; Lieberman JA; Dubois AEJ; Tsoumani M; Ciaccio CE; Portnoy JM; Mansfield LE; Fritz SB; Lanser BJ; Matz J; Oude Elberink HNG; Varshney P; Dilly SG; Adelman DC; Burks AW
    N Engl J Med; 2018 Nov; 379(21):1991-2001. PubMed ID: 30449234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peanut Oral Immunotherapy: State of the Art.
    Tang MLK; Lozinsky AC; Loke P
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):97-110. PubMed ID: 31761124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
    O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peanut Oral Immunotherapy With or Without H
    Chu DK; Freitag T; Marrin A; Walker TD; Avilla E; Freitag A; Spill P; Foster GA; Thabane L; Jordana M; Waserman S
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2386-2394. PubMed ID: 35643280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.